Paragraph IV certification under the Hatch-Waxman Act lets generic drugmakers challenge brand patents to speed up affordable drug entry. Learn how it works, why it succeeds, and how it saves patients billions.
Paragraph IV certification under the Hatch-Waxman Act lets generic drugmakers challenge brand patents to speed up affordable drug entry. Learn how it works, why it succeeds, and how it saves patients billions.
